Byers Capital

PinkDx is a biotechnology company specializing in women's health. It develops molecular tests to improve diagnostic outcomes for women with vague gynecological cancer symptoms, offering alternatives to invasive procedures. This enables more comfortable and efficient resolution of health concerns, providing timely and positive impacts on patients' lives.

Waltz Health is a company focused on innovating the pharmaceutical supply chain by developing technology-driven solutions for pricing, distribution, and prescription of medications. It collaborates with various partners, including consumers, payers, and pharmacies, to create smarter ways to manage prescription care. The company utilizes AI-driven marketplaces to reduce costs and offers consumer tools that enhance decision-making regarding healthcare. These tools provide users with better pricing, comprehensive information, and resources aimed at lowering expenses, empowering consumers, and enabling payers to effectively manage their pharmacy benefits. Through these efforts, Waltz Health strives to improve the overall experience and affordability of prescription medications.

Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

Getlabs is a digital health platform that facilitates at-home diagnostics. It enables healthcare organizations to send mobile phlebotomists to patients' homes nationwide for lab draws, vital checks, and advanced diagnostics, improving patient adherence and care gap closure.

Culdesac Inc. is a real estate development company based in San Francisco, California, focused on creating car-free residential neighborhoods in the United States. Established in 2018, the company's first project is in Tempe, Arizona, where it aims to build the first car-free neighborhood from scratch in the country. This innovative approach prioritizes pedestrian accessibility and eco-friendly living by eliminating parking spaces for residents while providing designated areas for visitors. The neighborhood will feature essential services such as grocery stores, coffee shops, coworking spaces, and market halls, allowing residents to engage with their community directly from their doorsteps. Culdesac's vision is to reimagine urban living by putting people before cars, fostering a sustainable and vibrant lifestyle.

Benchling, Inc. delivers a cloud-based informatics platform for life sciences research and development. The platform unifies experiment design, data capture, and collaboration in a single interface, enabling scientists to design, record, and share experiments. It consists of an integrated lab notebook, a biological registration system to track inventory such as plasmids, antibodies, and cell lines, and a molecular biology design and analysis suite that supports end-to-end R&D workflows. Additional modules include Benchling Insights for querying and visualizing structured data and collaboration around it, and Bioregistry for biological entity registration and strain management. Benchling serves researchers in biotechnology and pharmaceutical companies as well as academic and government labs, including research and development managers and principal investigators who need centralized data management and streamlined collaboration. The platform is applied across antibodies, cell therapy, gene therapy, proteins and peptides, vaccines, and industrial biotechnology. Founded in 2012 and based in San Francisco, Benchling enables scientists to design DNA, manage workflows, and accelerate decision-making throughout the R&D lifecycle.

Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.